Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease,Neurogastroenterology & Motility

当前位置： X-MOL 学术 › Neurogastroenterol. Motil. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease
Neurogastroenterology & Motility ( IF 3.5 ) Pub Date : 2021-09-01 , DOI: 10.1111/nmo.14256
Keeley M Fairbrass _{1,

2} , Christian P Selinger ₁ , David J Gracie _{1,

2} , Alexander C Ford _{1,

2}

Affiliation

Irritable bowel syndrome (IBS)-type symptoms are common in inflammatory bowel disease (IBD), but few studies have examined the prevalence and impact of IBS-type symptoms in IBD according to Rome IV criteria.

中文翻译：